Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,447 | -93,753 | -51,574 | -26,235 | 30,905 |
| Depreciation Amortization | 5,463 | 3,842 | 2,396 | 2,704 | 2,871 |
| Accounts receivable | -6,907 | -3,487 | 56 | 230 | 2,053 |
| Other Working Capital | 4,699 | 13,197 | -12,312 | -25,129 | -57,314 |
| Other Operating Activity | 42,855 | 22,927 | 14,512 | 502 | 719 |
| Operating Cash Flow | $-124,337 | $-57,274 | $-46,922 | $-47,928 | $-20,767 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,091 | -140,504 | -126,983 | N/A | 27,868 |
| PPE Investments | -2,720 | -4,664 | -846 | -189 | -165 |
| Investing Cash Flow | $-20,811 | $-145,168 | $-127,829 | $-189 | $27,703 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -49 | -4,996 | -6,944 | -7,186 |
| Common Stock Issued | 8,711 | 237,175 | 131,650 | N/A | 6 |
| Other Financing Activity | -4,650 | 0 | 60,785 | 29,355 | 0 |
| Financing Cash Flow | $154,061 | $237,126 | $187,439 | $22,411 | $-7,180 |
| Exchange Rate Effect | -639 | -350 | N/A | N/A | N/A |
| Beginning Cash Position | 49,748 | 15,414 | 2,726 | 28,432 | 28,675 |
| End Cash Position | 58,022 | 49,748 | 15,414 | 2,726 | 28,431 |
| Net Cash Flow | $8,274 | $34,334 | $12,688 | $-25,706 | $-244 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,337 | -57,274 | -46,922 | -47,928 | -20,767 |
| Capital Expenditure | -2,720 | -4,664 | -846 | -189 | -165 |
| Free Cash Flow | -127,057 | -61,938 | -47,768 | -48,117 | -20,932 |